Pages that link to "Q43975284"
Jump to navigation
Jump to search
The following pages link to Increased phasic activity of dopaminergic neurones in the rat ventral tegmental area following pharmacologically elevated levels of endogenous kynurenic acid (Q43975284):
Displaying 33 items.
- Kynurenine 3-monooxygenase polymorphisms: relevance for kynurenic acid synthesis in patients with schizophrenia and healthy controls (Q24623659) (← links)
- Downregulated kynurenine 3-monooxygenase gene expression and enzyme activity in schizophrenia and genetic association with schizophrenia endophenotypes (Q24631189) (← links)
- Kynurenine 3-Monooxygenase: An Influential Mediator of Neuropathology (Q26782867) (← links)
- Kynurenines in the mammalian brain: when physiology meets pathology (Q27003296) (← links)
- Glutamatergic synaptic dysregulation in schizophrenia: therapeutic implications. (Q30387014) (← links)
- Role of the NMDA-receptor in Prepulse Inhibition in the Rat. (Q30472936) (← links)
- Elevated levels of kynurenic acid in the cerebrospinal fluid of patients with bipolar disorder (Q33816563) (← links)
- Association study between kynurenine 3-monooxygenase gene and schizophrenia in the Japanese population. (Q34529112) (← links)
- Pro-inflammatory cytokines reduce the proliferation of NG2 cells and increase shedding of NG2 in vivo and in vitro. (Q35304641) (← links)
- N-Methyl-D-aspartate receptors as a target for improved antipsychotic agents: novel insights and clinical perspectives (Q36068372) (← links)
- Kynurenines, Parkinson's disease and other neurodegenerative disorders: preclinical and clinical studies. (Q36611537) (← links)
- Schizophrenia as an inflammation-mediated dysbalance of glutamatergic neurotransmission (Q36633620) (← links)
- A genome-wide association study of kynurenic acid in cerebrospinal fluid: implications for psychosis and cognitive impairment in bipolar disorder (Q37136385) (← links)
- The KMO allele encoding Arg452 is associated with psychotic features in bipolar disorder type 1, and with increased CSF KYNA level and reduced KMO expression (Q37186953) (← links)
- Pharmacological manipulation of kynurenic acid: potential in the treatment of psychiatric disorders (Q37378691) (← links)
- The role of parasites and pathogens in influencing generalised anxiety and predation-related fear in the mammalian central nervous system. (Q38004234) (← links)
- Kynurenic Acid in Schizophrenia: A Systematic Review and Meta-analysis (Q39130393) (← links)
- Increased levels of kynurenine and kynurenic acid in the CSF of patients with schizophrenia. (Q41771344) (← links)
- Anterior thalamic lesions produce chronic and profuse transcriptional de-regulation in retrosplenial cortex: A model of retrosplenial hypoactivity and covert pathology (Q42051311) (← links)
- Exposure to Kynurenic Acid during Adolescence Increases Sign-Tracking and Impairs Long-Term Potentiation in Adulthood (Q43092673) (← links)
- Inhibitory action of clozapine on rat ventral tegmental area dopamine neurons following increased levels of endogenous kynurenic acid (Q44515021) (← links)
- Clozapine and N-Methyl-d-Aspartate have positive modulatory actions on their respective discriminative stimulus properties in C57BL/6 mice (Q44960454) (← links)
- Elevated levels of kynurenic acid change the dopaminergic response to amphetamine: implications for schizophrenia (Q46364104) (← links)
- Subchronic treatment with kynurenine and probenecid: effects on prepulse inhibition and firing of midbrain dopamine neurons (Q46636521) (← links)
- Chronic neuroleptic treatment reduces endogenous kynurenic acid levels in rat brain (Q46933509) (← links)
- The ketamine-like compound methoxetamine substitutes for ketamine in the self-administration paradigm and enhances mesolimbic dopaminergic transmission. (Q47448107) (← links)
- Inhibition of Large Neutral Amino Acid Transporters Suppresses Kynurenic Acid Production Via Inhibition of Kynurenine Uptake in Rodent Brain (Q48055959) (← links)
- Cerebrospinal fluid kynurenic acid is associated with manic and psychotic features in patients with bipolar I disorder (Q48352892) (← links)
- Subchronic elevation of brain kynurenic acid augments amphetamine-induced locomotor response in mice. (Q48909056) (← links)
- Cerebrospinal fluid kynurenic acid in male patients with schizophrenia – correlation with monoamine metabolites (Q57844012) (← links)
- Age-related changes in neuroinflammation and prepulse inhibition in offspring of rats treated with Poly I:C in early gestation (Q64060608) (← links)
- Peripheral Biomarkers for First-Episode Psychosis-Opportunities from the Neuroinflammatory Hypothesis of Schizophrenia (Q64123533) (← links)
- Importance of kynurenine 3-monooxygenase for spontaneous firing and pharmacological responses of midbrain dopamine neurons: Relevance for schizophrenia (Q89026151) (← links)